Short Course Glucocorticoid Treatment for PTSD
| Status: | Completed |
|---|---|
| Conditions: | Psychiatric, Psychiatric |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 6/27/2018 |
| Start Date: | December 2004 |
| End Date: | January 2009 |
A Placebo-controlled, Randomized, Double-blind Comparison of Placebo vs Short Course Low Dose Corticosteroids on Posttraumatic Stress Disorder (PTSD)
The purpose of this study is to investigate if a 2-wk course of 20mg/day of oral prednisone
in addition to standard care will result in reduced PTSD symptoms or symptom severity
compared to placebo
in addition to standard care will result in reduced PTSD symptoms or symptom severity
compared to placebo
See attached document
Inclusion Criteria:
- Must meet DSM-IV criteria for PTSD w/ symptom exacerbation (CAPS score ≥ 50)
- Stable on other psychotropic meds x1 month
Exclusion Criteria:
- Current or past history of bipolar, schizophrenic, or other psychotic disorder
- Organic mental disorder
- Alcohol or substance abuse in last 3 months
- Clinically significant hepatic or renal disease or other acute or unstable medical
condition
- COPD, asthma, uncontrolled diabetes, rheumatologic diseases
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials